183 related articles for article (PubMed ID: 7041587)
1. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
3. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
Packer M; Medina N; Yushak M; Meller J
Circulation; 1983 Oct; 68(4):803-12. PubMed ID: 6352079
[TBL] [Abstract][Full Text] [Related]
6. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
7. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.
Davis R; Ribner HS; Keung E; Sonnenblick EH; LeJemtel TH
N Engl J Med; 1979 Jul; 301(3):117-21. PubMed ID: 221810
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
11. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
12. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
15. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
17. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
[TBL] [Abstract][Full Text] [Related]
18. Captopril in refractory heart failure: clinical and hemodynamic observations.
Abinader EG; Sharif D; Rosenfeld T; Malouf S
Cardiology; 1983; 70(6):326-32. PubMed ID: 6370433
[TBL] [Abstract][Full Text] [Related]
19. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
20. Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
Gottlieb SS; Kukin ML; Penn J; Fisher ML; Cines M; Medina N; Yushak M; Taylor M; Packer M
J Am Coll Cardiol; 1993 Oct; 22(4):963-7. PubMed ID: 8409070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]